ADMP Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

$0.68
As of 05/12/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  148,886,141
Average volume:  7,318,663
Market cap:   $108,016,895
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00547W208
ISIN:        US00547W2089
Sedol:      BH7QXJ9
Valuation   (See tab for details)
PE ratio:   -2.16
PB ratio:   19.32
PS ratio:   6.54
Return on equity:   -1,412.17%
Net income %:   -298.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy